Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8008079 | 0.88 | LMNA (0.46) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL186729 | 0.85 | MEN1 (0.56) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL3682708 | 0.85 | MEN1 (0.56) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL187458 | 0.85 | MEN1 (0.56) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL9488336 | 0.84 | LMNA (0.46) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL9488339 | 0.84 | LMNA (0.46) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL12394376 | 0.82 | LMNA (0.49) | MEN1KMT2ALMNARECQLAKR1C3 | |
| SCHEMBL7997621 | 0.81 | LMNA (0.41) | MEN1KMT2ALMNARECQLALDH1A1 | |
| SCHEMBL9823927 | 0.80 | KMT2A (0.46) | MEN1KMT2ALMNAALDH1A1KDM4E | |
| SCHEMBL9487033 | 0.80 | LMNA (0.51) | MEN1KMT2ALMNAALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0912586-B1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-16 | — | — | EP | disclosed |
| US-6169192-B1 | LIGANDS FOR TRANSITION METAL COMPLEXES SUITABLE FOR ENANTIOSELECTIVE HYDROGENATION OF ORGANIC DOUBLE OR TRIPLE BONDS | NOVARTIS AG (CH) | 2001-01-02 | — | — | US | disclosed |
| EP-0912586-A1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | Novartis AG (CH) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998001457-A1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | NOVARTIS AG (CH) | 1998-01-15 | — | — | WO | disclosed |